CLINICAL_TRIALS
trial_result
· 2023-07-12
Clinical Trial Update: Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001) [Phase 2]
Summary
Phase 2 trial update for preoperative gefitinib in EGFR-mutant II-IIIa non-small cell lung cancer (ECTOP-1001) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED